Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Their Alzheimer’s treatment worked — but shares fell anyway
Pharma Voice
Thursday, August 29, 2024 - 11:06am
tags:
Cognition Therapeutics, clinical trials, Alzheimer's disease, CT1812
GSK gets EU okay for RSV shot in younger age group
Pharmaphorum
Thursday, August 29, 2024 - 11:05am
tags:
GSK, Europe, vaccines, RSV, Arexvy
Eli Lilly’s lauded discount of its obesity drug Zepbound comes with caveats
Stat
Wednesday, August 28, 2024 - 9:24pm
tags:
Eli Lilly, Zepbound, DTC
House Oversight Chair challenges PBM leaders on alleged false statements
First Word Pharma
Wednesday, August 28, 2024 - 9:18pm
tags:
PBMs, CVS Caremark, Express Scripts, OptumRx
Insulet’s Trang Ly on overcoming ‘clinical inertia’ in diabetes care
Medtech Dive
Wednesday, August 28, 2024 - 9:14pm
tags:
Medtech, Insulet, type 2 diabetes, insulin pumps
FDA grants IND clearance for Find’s Phase I chronic optic neuropathy trial
Clinical Trials Arena
Wednesday, August 28, 2024 - 9:12pm
tags:
FDA, Find Therapeutics, IND, FTX-101, chronic optic neuropathy, clinical trials
UK unveils plans to plug up to $527M into clinical trials, manufacturing and more
Fierce Biotech
Wednesday, August 28, 2024 - 9:10pm
tags:
UK, drug manufacturing, clinical trials
Next up for Medtech: Being Generative in Domain-Specific Languages
Medical Devices and Diagnostics Industry
Wednesday, August 28, 2024 - 9:08pm
tags:
Medtech, artificial intelligence, generative AI
Patent thickets in federal government’s crosshairs as election 2024 looms
BioSpace
Wednesday, August 28, 2024 - 11:55am
tags:
patents, patent thickets, FTC, PTO, generics, biosimilars, 2024 Presidential election
EyePoint dinged with FDA warning letter over manufacturing shortfalls tied to eye implant
Fierce Pharma
Wednesday, August 28, 2024 - 11:47am
tags:
Eyepoint, FDA, eye implants, Medtech
Novartis taps Lindy to turn biologic drugs into at-home injectables, puts nearly $1B on the line
Fierce Pharma
Wednesday, August 28, 2024 - 11:46am
tags:
Novartis, Lindy Biosciences, drug delivery
Neurocrine's drug cuts schizophrenia symptoms in mid-stage study
Reuters
Wednesday, August 28, 2024 - 11:42am
tags:
Neurocrine Biosciences, schizophrenia, clinical trials, NBI-1117568
After an FDA rejection, here’s what’s next in the psychedelics pipeline
BioPharma Dive
Wednesday, August 28, 2024 - 11:41am
tags:
psychedelics, FDA, Lykos Therapeutics, COMPASS Pathways, Incannex Healthcare, MindMed
Bayer partners with NextRNA on lncRNA-targeted small molecules for cancer
First Word Pharma
Wednesday, August 28, 2024 - 11:38am
tags:
Bayer, NextRNA, IncRNAs, cancer
Genentech telegraphs 93 layoffs in California after sharing plans to shutter cancer immunology research unit
Fierce Biotech
Wednesday, August 28, 2024 - 11:36am
tags:
Genentech, Roche, layoffs, California
Feds killed plan to curb medicare advantage overbilling after industry opposition
Medical Marketing and Media
Wednesday, August 28, 2024 - 11:35am
tags:
Medicare, overbilling, patients
After obesity, Pfizer and Flagship pick 2 more targets for multibillion-dollar partnership
Fierce Biotech
Wednesday, August 28, 2024 - 11:33am
tags:
Pfizer, Flagship Pioneering, Quotient, ProFound Therapeutics
Novartis builds case for Leqvio with monotherapy data
Pharmaphorum
Wednesday, August 28, 2024 - 11:29am
tags:
Novartis, Leqvio, cholesterol, clinical trials
Jazz, Hikma must face 'reverse payment' claims over narcolepsy drug
Reuters
Tuesday, August 27, 2024 - 10:32pm
tags:
Jazz Pharma, Hikma, Xyrem, reverse payments, legal
After guiding Endo through bankruptcy, CEO Blaise Coleman exits suddenly
Fierce Pharma
Tuesday, August 27, 2024 - 8:11pm
tags:
Endo, Pharma CEOs, Blaise Coleman

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.